Nome do produto |
dissulfato de butirosina |
Sinônimos |
Sulfato de butirosina anidro [USAN]; Sulfato de butirosina; Sulfato de ambutirosina; Sulfato de butirosina anidro; Sulfato de butirosina; Sulfato de butirosina anidro; Butirosina, sulfato (sal); CL 642; D-estreptamina, O-2,6-diamino-2,6-dideoxi-alfa-D-glicopiranosil-(1-4)-O-(beta-D-xilofuranosil-(1-5))-N(sup 1)-(4-amino-2-hidroxi-1-oxobutil)-2-deoxi-(S)-, sulfato (1:2) (sal) di-hidratado com O-2,6-diamino-2,6-dideoxi-alfa-D-glicopiranosil-(1-4)-O-(beta-D-ribofuranosil-(1-5))-N(sup 1)-((S)-4-amino-2-hidroxi-1-oxobutil)-2-deoxi-D-estreptamina sulfato (1:2) (sal) anidro; O-2,6-Diamino-2,6-dideoxi-alfa-D-glicopiranosil-(1-4)-O-(beta-D-xilofuranosil-(1-5))-N(sup 1)-(4-amino-L-2-hidroxibutiril)-2-deoxi-D-estreptamina sulfato (1:2) (sal) di-hidratado com O-2,6-diamino-2,6-dideoxi-alfa-D-glicopiranosil-(1-4)-O-(beta-D-ribofuranosil-(1-5))-N(sup 1)-(4-amino-L-2-hidroxibutiril)-2-deoxi-D-estreptamina sulfato (1:2) (sal) anidro; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxi-alfa-D-glicopiranosil)oxi]-2-hidroxi-3-[(3xi)-beta-D-eritro-pentofuranosiloxi]ciclohexil}-2-hidroxibutanamida sulfato hidratado (1:2:2); 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-dideoxi-L-eritro-hexopiranosil)oxi]-2-hidroxi-3-(D-lisoxuranoloxi)ciclohexil]-2-hidroxibutanamida dissulfato (sal) |
Nome em inglês |
butirosin disulfate;Butirosin sulfate anhydrous [USAN]; Butirosin sulfate; Ambutyrosin sulfate; Butirosin sulfate anhydrous; Butirosin sulphate; Butirosin sulphate anhydrous; Butirosin, sulfate (salt); CL 642; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-((S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; O-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-[(3xi)-beta-D-erythro-pentofuranosyloxy]cyclohexyl}-2-hydroxybutanamide sulfate hydrate (1:2:2); 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-dideoxy-L-erythro-hexopyranosyl)oxy]-2-hydroxy-3-(D-lyxofuranosyloxy)cyclohexyl]-2-hydroxybutanamide disulfate (salt) |
Fórmula molecular |
C21H45N5O20S2 |
Peso Molecular |
751.7335 |
InChI |
InChI=1/C21H41N5O12.2H2O4S/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21;2*1-5(2,3)4/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34);2*(H2,1,2,3,4)/t6?,7?,8?,9?,10-,11+,12-,13?,14+,15-,16+,17?,18-,20?,21?;;/m1../s1 |
CAS Registry Number |
51022-98-1 |
Estrutura Molecular |
|
Ponto de ebulição |
947.4°C at 760 mmHg |
O ponto de inflamação |
526.8°C |
Pressão de vapor |
0mmHg at 25°C |
Símbolos de perigo |
|
Códigos de risco |
|
Descrição da Segurança |
|
|